The Apple Watch will be used by its manufacturer to detect irregular heart rhythms as part of a study to be conducted along with the Stanford University School of Medicine.
Apple announced that it had developed a Heart Study App that will look out for irregular heartbeats.
Apple said the app “is an innovative research study that uses data from Apple Watch to identify irregular heart rhythms, including those with potentially serious heart conditions such as atrial fibrillation (AFib).”
AFib is one of the most common forms of irregular heartbeats and a leading cause of stroke, the company stated.
Apple pointed out that AFib is responsible for at least 130,000 deaths and the hospital confinement of 750,000 people in the United States each year.
Data-gathering by Apple Watch
The company said the Watch’s heart rate sensor would collate data on irregular heart rhythms and notify users who may be experiencing AFib.
The sensor, according to a Mashable report, uses green LED lights that flash and light-sensitive photodiodes to monitor the amount of blood pumping through a Watch user’s wrist.
What makes the sensor unique is that it gather “signals from four distinct points on the wrist,” and along with software algorithms, the Watch “isolates heart rhythms from other noise (in the body).”
After a Watch user is notified about an irregular heart rhythm, he or she gets a free video consultation on his or her iPhone with the Heart Study’s medical professionals for further analysis.
The video consultation connects the user with a licensed primary care provider from American Well.
Apple chief operating officer (COO) Jeff Williams revealed that they’d get letters from customers every week, saying how the Watch has helped them discover that they have AFib.
He said the letters inspire them “to do more to help people understand their health” and perhaps help “advance discoveries in heart science.”
DISCLAIMER: This article expresses my own ideas and opinions. Any information I have shared are from sources that I believe to be reliable and accurate. I did not receive any financial compensation in writing this post, nor do I own any shares in any company I’ve mentioned. I encourage any reader to do their own diligent research first before making any investment decisions.
Candriam excludes 40 percent of all emerging markets
In a report, Bloomberg has used the Candriam SRI Bond Emerging Markets Fund as an example of how active fund...
What is the scope of the CFA franc reform in West Africa
The monetary system of the CFA franc zone, in general, is increasingly challenged, with France being accused of still maintaining...
Europe’s stock exchanges are in an optimal window to buy, says analyst
The declines of more than 3% during some moments of the session led the main stock markets of the Old...
The fintech company Joonko to cease operations after only 12 months of existence
The October 28th press release published by Joonko stated that the Series A financing round with existing and new investors,...
Asabys Partners leads a round of $20 million in Sidekick
Asabys has recently led a successful round of financing in Sidekick, a company specialized in digital therapies. This round will...
Featured7 days ago
Savills IM refinances two Italian assets with one of the first green loans in Italy
Business7 days ago
4 tips to market your small business locally
Business6 days ago
Major reasons why your website might not be attracting customers
Biotech6 days ago
Roche signs its new diabetes business manager in Spain to Isdin